Skip to main content

Table 1 Baseline characteristics

From: Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease

  N = 12
Age, years 66 ± 9
Men, n (%) 9 (75)
Diabetes mellitus, n (%) 7 (58)
Hyperlipidaemia, n (%) 12 (100)
Hypertension, n (%) 10 (83)
Current cigarette smoker, n (%) 6 (50)
Percutaneous coronary intervention, n (%) 10 (83)
Coronary artery bypass surgery, n (%) 7 (58)
Injected treatment site, n (%):  
   Inferior wall 7 (32)
   Lateral wall 2 (9)
   Anterior wall 5 (23)
   Septal wall 8 (36)
Medication at baseline, n (%)  
   Angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers 6 (50)
   Aspirin and/or clopidogrel 16 (100)
   β- blockers 12 (100)
   Calcium channel blockers 8 (67)
   Nitrates 12 (100)
   Statins 16 (100)
Medication at 6 months, n (%)  
   Angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers 6 (50)
   Aspirin and/or clopidogrel 16 (100)
   β- blockers 12 (100)
   Calcium channel blockers 7 (58)
   Nitrates 11 (92)
   Statins 16 (100)